Aurobindo Pharma

Buy Aurobindo Pharma; target of Rs 1390: Motilal Oswal

Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1390 in its research report dated February 10, 2026.

Stocks to Watch Today: Fractal Analytics, AYE, Manappuram, Alkem Labs, Zydus Life, Jubilant Pharmova, Fortis Healthcare, Azad Engineering, Precision Wires in focus on 16 February

Stocks to Watch, 16 Feb: Stocks like Ola Electric Mobility, Precision Wires India, Azad Engineering, Fortis Healthcare, Manappuram Finance, Lodha Developers, Deep Industries, Ashoka Buildcon, Aurobindo Pharma, Natco Pharma, Fractal Analytics, Aye Finance, and Jubilant Pharmova will be in focus on February 16.

Buy Aurobindo Pharma; target of Rs 1300: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated February 11, 2026.

Aurobindo Pharma receives 11 observations from USFDA; stock price flat

Aurobindo Pharma share price | At current levels, the stock is trading about 6.8 percent below its 52-week high and nearly 19.79 percent above its 52-week low.

Stocks to Watch Today: SBI, Aurobindo Pharma, Ipca Labs, Tata Steel, PFC, REC, Force Motors, Kalyan Jewellers, JK Tyre, Ram Ratna Wires, Atul Auto in focus on 09 February

Stocks to Watch, 09 Feb: Stocks like State Bank of India, Tata Steel, Shree Cement, Bosch, Oswal Pumps, HBL Engineering, SMS Pharmaceuticals, Sarda Energy and Minerals, Atul Auto, Krishna Institute of Medical Sciences, Ram Ratna Wires, JK Tyre and Industries, Whirlpool of India, and Godawari Power will be in focus on February 9.

Buy Aurobindo Pharma; target of Rs 1430: Motilal Oswal

Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1430 in its research report dated January 29, 2026.

Chartist Talk: Sudeep Shah bets on Indus Towers, Nestle India, City Union Bank for Budget day

Looking ahead, volatility is expected to pick up sharply over the next 2–3 sessions, with the Union Budget 2026 scheduled to be presented by the Finance Minister on February 1.

Trade Spotlight: How should you trade Pidilite, Fortis Healthcare, Sun Pharma, Emcure, Tata Consumer Products, and others on January 7?

Consolidation is expected to continue in the market for the next few sessions. Below are some short-term trading ideas to consider.

Stocks to Watch Today: South Indian Bank, Hyundai Motor, Hero MotoCorp, TVS Motor, RailTel, Aurobindo Pharma, Time Technoplast, MCX in focus on 2 January

Stocks to Watch, 2 January: Stocks like Punjab & Sind Bank, South Indian Bank, Indian Bank, Hyundai Motor India, Hero MotoCorp, TVS Motor, RailTel Corporation of India, Aurobindo Pharma, Time Technoplast, Vodafone Idea, and Multi Commodity Exchange of India will be in focus on January 2.

Trade Spotlight: How should you trade Ramco Cements, BSE, Aurobindo Pharma, Tech Mahindra, APL Apollo Tubes, and others on December 19?

The market may attempt a bounce back after a four-day losing streak, but sustainability will be key to watch. Below are some short-term trading ideas to consider.

Stocks to Watch Today: Wakefit, Corona Remedies, Dr Reddys Labs, Wipro, Aurobindo Pharma, NLC India, Ashoka Buildcon, KEC in focus on 15 December

Stocks to Watch, 15 December: Stocks like Wipro, Dr Reddy's Laboratories, SMS Pharmaceuticals, Aurobindo Pharma, ESAF Small Finance Bank, NLC India, Ashoka Buildcon, KEC International, Bharat Electronics, Astra Microwave Products, One 97 Communications Paytm, Refex Industries, and Brigade Enterprises will be in focus on December 15.

Buy Aurobindo Pharma; target of Rs 1430: Motilal Oswal

Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1430 in its research report dated December 03, 2025.

Aurobindo Pharma incurring loss at China Plant; hopes to achieve break-even by Q4

The Hyderabad-based drug major remains confident about sustaining its growth momentum and driving value creation across all businesses, CFO S Subramanian said

Trade Spotlight: How should you trade Tata Communications, SAIL, Aurobindo Pharma, Samvardhana Motherson, Five-Star, and others on November 14?

The market is expected to remain rangebound until it decisively surpasses the previous day’s high. Below are some short-term trading ideas to consider.

Buy Aurobindo Pharma; target of Rs 1350: Motilal Oswal

Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1350 in its research report dated November 06, 2025.

Trade Spotlight: How should you trade Tech Mahindra, Aurobindo Pharma, Garden Reach, Bharat Forge, M&M, and others on November 12?

The market is likely to stay in positive terrain with improving sentiment. Below are some short-term trading ideas to consider.

Buy Aurobindo Pharma; target of Rs 1350: ICICI Securities

ICICI Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1350 in its research report dated November 07, 2025.

Trade Spotlight: How should you trade Aurobindo Pharma, LIC, Godrej Properties, Punjab National Bank, Bharat Airtel, Cummins, and others on November 4?

The consolidation amid range-bound trading may continue in the upcoming sessions due to a lack of triggers. Below are some short-term trading ideas to consider.

Trade Spotlight: How should you trade Federal Bank, NALCO, Eternal, KEI Industries, Karur Vysya Bank, and others on October 09?

The market is expected to consolidate further until a decisive breakout above the previous day's high occurs. Below are some short-term trading ideas to consider.

Aurobindo Pharma shares rise 4.5% as report says GTCR strikes $4.8-bn deal to buy Zentiva

A report said last month that Aurobindo Pharma was leading the race to buy Zentiva for up to $5.5 billion

Aurobindo Pharma shares fall on eight observations from USFDA

Aurobindo Pharma Share Price |